Showing results (371-380 of 1,299) with videos related to

Sort By:
Pageof 130
JAMA Cardiology|November 29, 2016
Outcomes and Temporal Trends of Inpatient Percutaneous Coronary Intervention at Centers With and Without On-site Cardiac Surgery in the United StatesKashish Goel, Tanush Gupta, Dhaval Kolte, et al.
JAMA Cardiology|November 29, 2016
Assessment of Use vs Discontinuation of Oral Anticoagulation After Pulmonary Vein Isolation in Patients With Atrial FibrillationSara Själander, Fredrik Holmqvist, J Gustav Smith, et al.
JAMA Cardiology|October 13, 2016
A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast CancerHusam Abdel-Qadir, Peter C Austin, Douglas S Lee, et al.
JAMA Cardiology|December 22, 2016
Use of Risk Models to Predict Death in the Next Year Among Individual Ambulatory Patients With Heart FailureLarry A Allen, Daniel D Matlock, Susan M Shetterly, et al.
JAMA Cardiology|December 29, 2016
Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure ProgramAmbarish Pandey, Harsh Golwala, Shubin Sheng, et al.
JAMA Cardiology|March 19, 2017
Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore CathetersBjörn Redfors, Brendan M Watson, Thomas McAndrew, et al.
JAMA Cardiology|March 19, 2017
Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart StudyRavi V Shah, Aferdita Spahillari, Stanford Mwasongwe, et al.
JAMA Cardiology|March 23, 2017
Sudden Cardiac Arrest Risk Assessment: Population Science and the Individual Risk MandateRobert J Myerburg, Jeffrey J Goldberger
JAMA Cardiology|March 15, 2017
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT TrialRobert P Giugliano, Stephen D Wiviott, Michael A Blazing, et al.
JAMA Cardiology|March 15, 2017
Long-term Low-Density Lipoprotein Cholesterol-Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia: Results Up to 4 Years From the Open-Label OSLER-1 Extension StudyMichael J Koren, Marc S Sabatine, Robert P Giugliano, et al.
Pageof 130